VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2020 | The evolving migraine prevention landscape: EAN 2020 highlights

Messoud Ashina • 29 May 2020
EAN 2020
Headache
Perspectives Prevention Treatment

Messoud Ashina, MD, PhD, DMSc, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark, shares his key take-home messages from the European Academy of Neurology 2020 Virtual Congress symposium on anti-CGRP monoclonal antibodies and the evolving migraine prevention landscape. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Messoud Ashina

2:44
PROMISE-1: eptinezumab in episodic migraine
Messoud Ashina • 29 May 2020
2:24
Latest guidelines on anti-CGRP antibodies: first-line and long-term use
Messoud Ashina • 23 Jun 2022
3:04
PACAP as a future target for anti-migraine medication
Messoud Ashina • 23 Jun 2022
4:14
BKCa channels: potential novel anti-migraine target
Messoud Ashina • 29 May 2020

Related Videos

2:58
Exploring the link between migraine and psychiatric comorbidities
Claudia Altamura • 2 Jul 2023
2:01
Targeting CGRP: Is it better to target the ligand or receptor in migraine prevention?
Claudia Altamura • 2 Jul 2023
0:53
Factors influencing genetic testing for hemiplegic migraine
Irene de Boer • 1 Jul 2023
2:16
How to integrate gepants into migraine clinical care
Alan Rapoport • 1 Jul 2023
The content of VJNeurology is intended for healthcare professionals